Biotricity, Inc., a medical diagnostic and consumer healthcare technology company, reported it has received 510 clearance from the U.S. Food and Drug Administration for its Biotres Cardiac Monitoring Device, a three lead device for ECG and arrhythmia monitoring that is intended for lower risk patients.
January 24, 2022
· 5 min read